世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic) - Global Forecast to 2027


The global bronchoscopy market is projected to reach USD 3.7 Billion by 2027 from USD 2.5 Billion in 2022, at a CAGR of 7.9% during the forecasted period (2022 to 2027). Market growth is largely dr... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ
2022年9月9日 US$4,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
278 349 英語

日本語のページは自動翻訳を利用し作成しています。


 

Summary

The global bronchoscopy market is projected to reach USD 3.7 Billion by 2027 from USD 2.5 Billion in 2022, at a CAGR of 7.9% during the forecasted period (2022 to 2027). Market growth is largely driven by the rising prevalence of respiratory diseases, the growing demand for minimally invasive surgeries, growing hospital investments in bronchoscopy facilities, and technological advancements in bronchoscopes. On the other hand, the dearth of trained physicians and pulmonologists is a major challenge to the growth of this market.

“The Bronchoscopes are accounted to hold the largest share of the bronchoscopy market, by product in 2021.”
Based on product, the bronchoscopy equipment market is segmented into bronchoscopes, imaging systems, accessories, and other bronchoscopy equipment. The bronchoscopes segment accounted for the largest share of the bronchoscopy equipment market in 2021. The large share of this segment can be attributed to the high cost of bronchoscopes compared to imaging systems and accessories, the increasing prevalence of lung cancer, and technological advancements

“The Bronchial treatment are accounted to hold the largest share of the bronchoscopy market, by application in 2021.”
Based on application, the bronchoscopy equipment market is segmented into bronchial treatment and bronchial diagnosis. In 2021, the bronchial treatment segment accounted for the largest share of the market. The large share of this segment can be attributed to the rising prevalence of target diseases.

“North America commanded the largest share of the bronchoscopy in 2021.”
Based on region, the bronchoscopy equipment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America has the largest share of the bronchoscopy equipment market. The large share of the North American market can be attributed to the increasing incidence and prevalence of chronic respiratory diseases, favorable reimbursement scenario in the US, the rising incidence of lung cancer in Canada, rapid increase in healthcare expenditure, easy accessibility to advanced technologies, and the strong presence of market players in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
• By Region: North America (33%), Europe (24%), AsiaPacific (27%), and Rest of the World (16%)

Some of the major players operating in this market Olympus Corporation (Japan), KARL STORZ (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), and FUJIFILM Holdings Corporation (Japan),

List of Companies Profiled in the Report
• Olympus Corporation (Japan)
• KARL STORZ (Germany)
• Ambu A/S (Denmark)
• Boston Scientific Corporation (US)
• Ethicon (US)
• FUJIFILM Holdings Corporation (Japan)
• Medtronic (Ireland)
• HOYA Corporation (Japan)
• Richard Wolf GmbH (Germany)
• Cook Medical (US)
• Broncus Medical Inc. (China)
• CONMED (US)
• Roper Technologies (US)
• Teleflex Incorporated (US)
• Laborie Medical Technologies Corp. (Canada)
• EFER Endoscopy (France)
• EMOS Technology GmbH (Germany)
• VBM Medizintechnik GmbH (Germany)
• Hunan Vathin Medical Instrument Co. Ltd. (China)
• Machida Endoscope Co. Ltd. (China)

Research Coverage
This report studies the bronchoscopy equipment market based on product, application, usability, patient and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total bronchoscopy equipment market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on bronchoscopy equipment offered by the top 20 players in the bronchoscopy equipment market. The report analyzes the bronchoscopy market product, application, usability, patient and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bronchoscopy equipment market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the bronchoscopy market

ページTOPに戻る


Table of Contents

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.3 MARKET SCOPE 40
1.3.1 MARKET SEGMENTATION 40
1.3.2 GEOGRAPHIC SCOPE 41
1.3.3 YEARS CONSIDERED 41
1.4 CURRENCY 42
1.5 LIMITATIONS 42
1.6 STAKEHOLDERS 42
1.7 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 1 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 46
2.1.2 PRIMARY DATA 46
FIGURE 2 PRIMARY SOURCES 46
2.1.2.1 Key data from primary sources 47
2.1.2.2 Key industry insights 48
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 48
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.2 MARKET SIZE ESTIMATION 49
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION 50
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF BRONCHOSCOPY EQUIPMENT MARKET 50
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51
FIGURE 8 TOP-DOWN APPROACH 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53
FIGURE 9 DATA TRIANGULATION METHODOLOGY 53
2.4 MARKET SHARE ANALYSIS 54
2.5 STUDY ASSUMPTIONS 54
2.6 RISK ASSESSMENT/FACTOR ANALYSIS 54
TABLE 1 RISK ANALYSIS 54
3 EXECUTIVE SUMMARY 55
FIGURE 10 BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 55
FIGURE 11 BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 56
FIGURE 12 BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2022 VS. 2027 (USD MILLION) 56
FIGURE 13 BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2022 VS. 2027 (USD MILLION) 57
FIGURE 14 BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 57
FIGURE 15 BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 58
4 PREMIUM INSIGHTS 59
4.1 BRONCHOSCOPY EQUIPMENT MARKET OVERVIEW 59
FIGURE 16 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 59
4.2 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT AND COUNTRY (2021) 60
FIGURE 17 BRONCHOSCOPES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 60
4.3 GEOGRAPHICAL SNAPSHOT OF BRONCHOSCOPY EQUIPMENT MARKET 61
FIGURE 18 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
FIGURE 19 BRONCHOSCOPY EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
5.2.1 DRIVERS 63
5.2.1.1 Rising prevalence of respiratory diseases 63
5.2.1.2 Increasing cases of lung cancer 63
TABLE 2 LUNG CANCER INCIDENCE, BY COUNTRY, 2020 63
5.2.1.3 Growing demand for minimally invasive surgeries 64
5.2.1.4 Growing hospital investments in bronchoscopy facilities 64
5.2.1.5 Technological advancements 65
5.2.2 RESTRAINTS 65
5.2.2.1 High overhead cost of bronchoscopy procedures 65
TABLE 3 AGE, NUMBER OF REPAIRS, AVERAGE REPAIR COST PER BREAKAGE, RANGE OF REPAIR COST, AND TOTAL REPAIR COST BY SCOPE OVER A 3-YEAR PERIOD (MAY 2018–APRIL 2021) 66
5.2.2.2 Risks associated with bronchoscopy 66
5.2.3 OPPORTUNITIES 67
5.2.3.1 Growing healthcare market in emerging economies 67
FIGURE 20 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRICS COUNTRIES, 2012–2019 68
5.2.4 CHALLENGES 68
5.2.4.1 Dearth of trained physicians and pulmonologists 68
5.2.5 BURNING ISSUES 68
5.2.5.1 Product recalls 68
TABLE 4 LIST OF PRODUCT RECALLS 68
5.3 RANGES/SCENARIOS 69
FIGURE 21 REALISTIC SCENARIO 69
FIGURE 22 PESSIMISTIC SCENARIO 70
FIGURE 23 OPTIMISTIC SCENARIO 70
5.4 REGULATORY ANALYSIS 71
TABLE 5 LIST OF REGULATORY AUTHORITIES 71
5.4.1 NORTH AMERICA 71
5.4.1.1 US 71
TABLE 6 US: FDA MEDICAL DEVICE CLASSIFICATION 72
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72
5.4.1.2 Canada 73
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73
5.4.2 EUROPE 73
5.4.3 ASIA PACIFIC 73
5.4.3.1 Japan 73
TABLE 9 JAPAN: CLASSIFICATION OF MEDICAL DEVICES 74
5.4.3.2 China 74
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74
5.4.3.3 India 76
5.5 PORTER’S FIVE FORCES ANALYSIS 77
5.5.1 THREAT OF NEW ENTRANTS 77
5.5.1.1 High capital requirement 77
5.5.1.2 High preference for products from well-established brands 77
5.5.2 THREAT OF SUBSTITUTES 77
5.5.2.1 Substitute therapies for bronchoscopy 77
5.5.3 BARGAINING POWER OF SUPPLIERS 78
5.5.3.1 Presence of several raw material suppliers 78
5.5.3.2 Supplier switching cost 78
5.5.4 BARGAINING POWER OF BUYERS 78
5.5.4.1 Few companies offer premium products at global level 78
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.5.5.1 Increasing demand for high-quality and innovative products 78
5.5.5.2 Lucrative growth potential in emerging markets 78
5.6 SUPPLY CHAIN ANALYSIS 79
FIGURE 24 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 79
5.7 VALUE CHAIN ANALYSIS 80
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 80
5.8 ECOSYSTEM ANALYSIS 81
FIGURE 26 ECOSYSTEM ANALYSIS OF BRONCHOSCOPY EQUIPMENT MARKET 81
5.8.1 ROLE IN ECOSYSTEM 81
FIGURE 27 KEY PLAYERS IN BRONCHOSCOPY EQUIPMENT MARKET ECOSYSTEM 82
5.9 TECHNOLOGY ANALYSIS 82
5.10 KEY CONFERENCES AND EVENTS IN 2022–2023 83
TABLE 11 BRONCHOSCOPY EQUIPMENT MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 83
5.11 PATENT ANALYSIS 86
5.11.1 PATENT TRENDS FOR BRONCHOSCOPY EQUIPMENT 86
FIGURE 28 PATENT TRENDS FOR BRONCHOSCOPES, JANUARY 2011–AUGUST 2022 86
5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 86
FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BRONCHOSCOPES PATENTS, JANUARY 2011— AUGUST 2022 87
5.12 TRADE ANALYSIS 87
TABLE 12 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017–2021 (USD MILLION) 87
TABLE 13 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017–2021 (USD MILLION) 88
5.13 PRICING ANALYSIS 88
TABLE 14 AVERAGE SELLING PRICE OF BRONCHOSCOPES 88
TABLE 15 COST OF BRONCHOSCOPY EQUIPMENT 88
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 91
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 91
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 91
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 91
5.14.2 BUYING CRITERIA 91
FIGURE 31 KEY BUYING CRITERIA FOR END USERS OF BRONCHOSCOPY EQUIPMENT 91
TABLE 17 KEY BUYING CRITERIA FOR END USERS OF BRONCHOSCOPY EQUIPMENT 92
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 92
5.15.1 REVENUE POCKETS FOR BRONCHOSCOPY EQUIPMENT MANUFACTURERS 92
FIGURE 32 REVENUE SHIFT FOR BRONCHOSCOPY EQUIPMENT 92
6 BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT 93
6.1 INTRODUCTION 94
TABLE 18 BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94
6.2 BRONCHOSCOPES 94
TABLE 19 FLEXIBLE VS. RIGID BRONCHOSCOPY 95
TABLE 20 INDICATIONS FOR FLEXIBLE AND RIGID BRONCHOSCOPY 95
TABLE 21 BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 22 BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 96
6.2.1 BY TYPE 96
6.2.1.1 Flexible bronchoscopes 96
6.2.1.1.1 Most widely adopted bronchoscopes 96
TABLE 23 ADVANTAGES AND DISADVANTAGES OF FLEXIBLE BRONCHOSCOPES 97
TABLE 24 FLEXIBLE BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 97
6.2.1.2 Rigid bronchoscopes 97
6.2.1.2.1 Complications associated with rigid bronchoscopy to limit adoption 97
TABLE 25 ADVANTAGES AND DISADVANTAGES OF RIGID BRONCHOSCOPES 98
TABLE 26 RIGID BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 98
6.2.1.3 EBUS bronchoscopes 98
6.2.1.3.1 EBUS bronchoscopes to register steady growth during forecast period 98
TABLE 27 EBUS BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 99
6.2.2 BY WORKING CHANNEL DIAMETER 99
TABLE 28 BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 99
6.2.2.1 2.8 mm 99
6.2.2.1.1 2.8 mm segment to account for largest market share 99
TABLE 29 2.8 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 100
6.2.2.2 2.2 mm 100
6.2.2.2.1 2.2 mm bronchoscopes mainly used in pediatric patients 100
TABLE 30 2.2 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 100
6.2.2.3 3.0 mm 101
6.2.2.3.1 Patient discomfort associated with 3.0 mm diameters limits market growth 101
TABLE 31 3.0 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 101
6.2.2.4 Other working channel diameters 101
TABLE 32 BRONCHOSCOPES MARKET FOR OTHER WORKING CHANNEL DIAMETERS, BY REGION, 2020–2027 (USD MILLION) 102
6.3 IMAGING SYSTEMS 102
TABLE 33 BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 34 BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 103
6.3.1 VIDEO PROCESSORS 103
6.3.1.1 Video processors to register highest growth during forecast period 103
TABLE 35 VIDEO PROCESSORS MARKET, BY REGION, 2020–2027 (USD MILLION) 103
6.3.2 LIGHT SOURCES 104
6.3.2.1 Light sources essential components of bronchoscopy visualization systems 104
TABLE 36 LIGHT SOURCES MARKET, BY REGION, 2020–2027 (USD MILLION) 104
6.3.3 CAMERA HEADS 104
6.3.3.1 Technological advancements support market growth 104
6.3.3.2 Single-chip cameras 104
6.3.3.3 3-chip cameras 104
6.3.3.4 HD cameras 104
6.3.3.5 3D cameras 105
6.3.3.6 4K camera heads 105
TABLE 37 CAMERA HEADS MARKET, BY REGION, 2020–2027 (USD MILLION) 105
6.3.4 WIRELESS DISPLAYS AND MONITORS 105
6.3.4.1 Essential in diagnostic and therapeutic procedures 105
TABLE 38 WIRELESS DISPLAYS AND MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 106
6.3.5 OTHER COMPONENTS 106
TABLE 39 OTHER COMPONENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 106
6.4 ACCESSORIES 107
TABLE 40 BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 41 BRONCHOSCOPY ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION) 107
6.4.1 CYTOLOGY BRUSHES 108
6.4.1.1 Used to collect cell samples from bronchus 108
TABLE 42 CYTOLOGY BRUSHES MARKET, BY REGION, 2020–2027 (USD MILLION) 108
6.4.2 TRANSBRONCHIAL ASPIRATION NEEDLES 108
6.4.2.1 Transbronchial aspiration needles projected to witness highest growth during forecast period 108
TABLE 43 TRANSBRONCHIAL ASPIRATION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 108
6.4.3 BIOPSY FORCEPS 109
6.4.3.1 Biopsy forceps aid in diagnosing malignant and nonmalignant disorders 109
TABLE 44 BIOPSY FORCEPS MARKET, BY REGION, 2020–2027 (USD MILLION) 109
6.4.4 BIOPSY VALVES 109
6.4.4.1 Biopsy valves designed for one-time use 109
TABLE 45 BIOPSY VALVES MARKET, BY REGION, 2020–2027 (USD MILLION) 110
6.4.5 CLEANING BRUSHES 110
6.4.5.1 Stringent regulations for cleaning bronchoscopes to drive market 110
TABLE 46 CLEANING BRUSHES MARKET, BY REGION, 2020–2027 (USD MILLION) 110
6.4.6 MOUTHPIECES 111
6.4.6.1 Growing number of bronchoscopy procedures performed to support adoption of mouthpieces 111
TABLE 47 MOUTHPIECES MARKET, BY REGION, 2020–2027 (USD MILLION) 111
6.4.7 OTHER ACCESSORIES 111
TABLE 48 OTHER ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION) 112
6.5 OTHER BRONCHOSCOPY EQUIPMENT 112
TABLE 49 OTHER BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 113
7 BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION 114
7.1 INTRODUCTION 115
TABLE 50 DIAGNOSTIC AND THERAPEUTIC APPLICATIONS OF BRONCHOSCOPY 115
TABLE 51 BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
7.2 BRONCHIAL TREATMENT 116
7.2.1 LARGEST AND FASTEST-GROWING MARKET SEGMENT 116
TABLE 52 BRONCHOSCOPY EQUIPMENT MARKET FOR BRONCHIAL TREATMENT, BY REGION, 2020–2027 (USD MILLION) 116
7.3 BRONCHIAL DIAGNOSIS 116
7.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE MARKET 116
TABLE 53 NUMBER OF DIAGNOSTIC BRONCHOSCOPY PROCEDURES WITH OR WITHOUT BIOPSY, BY COUNTRY, 2014–2018 117
TABLE 54 BRONCHOSCOPY EQUIPMENT MARKET FOR BRONCHIAL DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION) 117
8 BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY 118
8.1 INTRODUCTION 119
TABLE 55 BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 119
8.2 REUSABLE EQUIPMENT 119
8.2.1 REUSABLE EQUIPMENT OFFERS HIGH IMAGE QUALITY 119
TABLE 56 REUSABLE BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 120
8.3 DISPOSABLE EQUIPMENT 120
8.3.1 DISPOSABLE EQUIPMENT SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 120
TABLE 57 DISPOSABLE BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 121
9 BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT 122
9.1 INTRODUCTION 123
TABLE 58 BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 123
9.2 ADULT PATIENTS 123
9.2.1 HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES IN ADULT PATIENTS MAJOR FACTOR DRIVING MARKET GROWTH 123
TABLE 59 BRONCHOSCOPY EQUIPMENT MARKET FOR ADULT PATIENTS, BY REGION, 2020–2027 (USD MILLION) 124
9.3 PEDIATRIC PATIENTS 124
9.3.1 IMPROVING HEALTHCARE INFRASTRUCTURE IN EMERGING COUNTRIES TO SUPPORT MARKET GROWTH 124
TABLE 60 RIGID BRONCHOSCOPE SIZES FOR CHILDREN 124
TABLE 61 BRONCHOSCOPY EQUIPMENT MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2020–2027 (USD MILLION) 125
10 BRONCHOSCOPY EQUIPMENT MARKET, BY END USER 126
10.1 INTRODUCTION 127
TABLE 62 MEDICARE NATIONAL AVERAGE COVERAGE FOR BRONCHOSCOPY PROCEDURES AT HOSPITALS, AMBULATORY SURGERY CENTERS, AND IN-OFFICE FACILITIES, 2019 127
TABLE 63 BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 128
10.2 HOSPITALS 128
10.2.1 LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR BRONCHOSCOPY EQUIPMENT 128
TABLE 64 BRONCHOSCOPY EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 129
10.3 AMBULATORY SURGERY CENTERS/CLINICS 130
10.3.1 COST-EFFECTIVENESS OF ASCS TO DRIVE MARKET 130
TABLE 65 US: NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS, 2013–2017 130
TABLE 66 US: AMBULATORY SURGERY CENTER PROCEDURES, 2015–2021 (MILLION) 130
TABLE 67 US: AMBULATORY SURGERY CENTERS, BY STATE, 2019 131
TABLE 68 BRONCHOSCOPY EQUIPMENT MARKET FOR AMBULATORY SURGERY CENTERS/CLINICS, BY REGION, 2020–2027 (USD MILLION) 131
11 BRONCHOSCOPY EQUIPMENT MARKET, BY REGION 132
11.1 INTRODUCTION 133
TABLE 69 LUNG CANCER CASES, BY REGION, 2020 133
TABLE 70 DEATHS DUE TO LUNG CANCER, BY REGION, 2020 133
TABLE 71 FIVE-YEAR PREVALENCE OF LUNG CANCER, BY REGION, 2020 134
TABLE 72 BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 134
11.2 NORTH AMERICA 135
FIGURE 33 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET SNAPSHOT 135
TABLE 73 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 74 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 136
TABLE 75 NORTH AMERICA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 76 NORTH AMERICA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 137
TABLE 77 NORTH AMERICA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 78 NORTH AMERICA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 79 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 138
TABLE 80 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 138
TABLE 81 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 139
TABLE 82 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 139
11.2.1 US 139
11.2.1.1 Largest market for bronchoscopy equipment due to high healthcare spending 139
TABLE 83 US: LUNG CANCER INCIDENCE, 2020 VS. 2040 139
TABLE 84 US: KEY MACROINDICATORS 140
TABLE 85 MEDICARE COVERAGE FOR BRONCHOSCOPY PROCEDURES 140
TABLE 86 US: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 141
TABLE 87 US: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 88 US: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 142
TABLE 89 US: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 90 US: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 91 US: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 92 US: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 143
TABLE 93 US: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 143
TABLE 94 US: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 143
11.2.2 CANADA 144
11.2.2.1 Long waiting period for bronchoscopy procedures to restrain market growth 144
TABLE 95 CANADA: LUNG CANCER INCIDENCE, 2018 VS. 2025 144
TABLE 96 CANADA: KEY MACROINDICATORS 145
TABLE 97 CANADA: MEDIAN PATIENT WAITING PERIODS FOR TREATMENT AFTER APPOINTMENT WITH SPECIALISTS FOR BRONCHOSCOPY (2018) 145
TABLE 98 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145
TABLE 99 CANADA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 100 CANADA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 146
TABLE 101 CANADA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 102 CANADA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 103 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
TABLE 104 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 147
TABLE 105 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 148
TABLE 106 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 148
11.3 EUROPE 148
TABLE 107 EUROPE: ESTIMATED AGE-STANDARDIZED INCIDENCE RATE OF LUNG CANCER, BY COUNTRY, 2020 148
TABLE 108 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 109 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
TABLE 110 EUROPE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 111 EUROPE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 151
TABLE 112 EUROPE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 113 EUROPE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 114 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
TABLE 115 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 152
TABLE 116 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 153
TABLE 117 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 153
11.3.1 GERMANY 153
11.3.1.1 Germany dominates European bronchoscopy equipment market 153
TABLE 118 GERMANY: LUNG CANCER INCIDENCE, 2018 VS. 2025 153
TABLE 119 GERMANY: KEY MACROINDICATORS 154
TABLE 120 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 154
TABLE 121 GERMANY: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 122 GERMANY: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 155
TABLE 123 GERMANY: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 124 GERMANY: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 125 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
TABLE 126 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 156
TABLE 127 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 157
TABLE 128 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 157
11.3.2 UK 157
11.3.2.1 Supportive reimbursement policies to drive market 157
TABLE 129 UK: KEY MACROINDICATORS 158
TABLE 130 REIMBURSEMENT FOR BRONCHOSCOPY PROCEDURES IN THE UK 158
TABLE 131 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159
TABLE 132 UK: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 133 UK: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 159
TABLE 134 UK: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 135 UK: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 136 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 137 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 161
TABLE 138 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 161
TABLE 139 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 161
11.3.3 FRANCE 161
11.3.3.1 Favorable health insurance system to drive market for bronchoscopy equipment 161
TABLE 140 FRANCE: LUNG CANCER INCIDENCE, 2020 VS. 2040 162
TABLE 141 FRANCE: KEY MACROINDICATORS 162
TABLE 142 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162
TABLE 143 FRANCE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 144 FRANCE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 163
TABLE 145 FRANCE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 146 FRANCE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 147 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
TABLE 148 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 164
TABLE 149 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 165
TABLE 150 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 165
11.3.4 SPAIN 165
11.3.4.1 Well-organized and efficient healthcare system to offer growth opportunities 165
TABLE 151 SPAIN: LUNG CANCER INCIDENCE, 2018 VS. 2025 166
TABLE 152 SPAIN: KEY MACROINDICATORS 166
TABLE 153 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 166
TABLE 154 SPAIN: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 155 SPAIN: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 167
TABLE 156 SPAIN: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 157 SPAIN: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 158 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 159 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 168
TABLE 160 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 169
TABLE 161 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 169
11.3.5 ITALY 169
11.3.5.1 Growing medical tourism and rising geriatric population key factors driving market 169
TABLE 162 ITALY: LUNG CANCER INCIDENCE, 2018 VS. 2025 170
TABLE 163 ITALY: KEY MACROINDICATORS 170
TABLE 164 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 165 ITALY: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 166 ITALY: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 171
TABLE 167 ITALY: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 168 ITALY: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 169 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 170 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 172
TABLE 171 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 173
TABLE 172 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 173
11.3.6 REST OF EUROPE 173
TABLE 173 REST OF EUROPE: LUNG CANCER INCIDENCE, 2020 VS. 2040 174
TABLE 174 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP) 174
TABLE 175 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 174
TABLE 176 REST OF EUROPE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 177 REST OF EUROPE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 175
TABLE 178 REST OF EUROPE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 REST OF EUROPE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 180 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 176
TABLE 181 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 176
TABLE 182 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 177
TABLE 183 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 177
11.4 ASIA PACIFIC 177
TABLE 184 ASIA PACIFIC: ESTIMATED AGE-STANDARDIZED INCIDENCE RATE FOR LUNG CANCER, BY COUNTRY, 2020 177
FIGURE 34 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET SNAPSHOT 179
TABLE 185 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 180
TABLE 186 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 180
TABLE 187 ASIA PACIFIC: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 188 ASIA PACIFIC: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 181
TABLE 189 ASIA PACIFIC: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 190 ASIA PACIFIC: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 191 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182
TABLE 192 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 182
TABLE 193 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 182
TABLE 194 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 183
11.4.1 CHINA 183
11.4.1.1 Large patient population to favor market growth 183
TABLE 195 CHINA: KEY MACROINDICATORS 184
TABLE 196 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 184
TABLE 197 CHINA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 198 CHINA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 185
TABLE 199 CHINA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 200 CHINA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 201 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 186
TABLE 202 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 186
TABLE 203 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 186
TABLE 204 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 186
11.4.2 JAPAN 187
11.4.2.1 Growing geriatric population to support market growth 187
TABLE 205 JAPAN: LUNG CANCER INCIDENCE, 2020 VS. 2040 187
TABLE 206 JAPAN: KEY MACROINDICATORS 188
TABLE 207 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 188
TABLE 208 JAPAN: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 209 JAPAN: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 189
TABLE 210 JAPAN: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 211 JAPAN: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 212 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 190
TABLE 213 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 190
TABLE 214 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 190
TABLE 215 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 190
11.4.3 INDIA 191
11.4.3.1 Healthcare infrastructural development and favorable government initiatives key factors supporting market growth 191
TABLE 216 INDIA: LUNG CANCER INCIDENCE, 2018 VS. 2025 191
TABLE 217 INDIA: KEY MACROINDICATORS 191
TABLE 218 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 192
TABLE 219 INDIA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 220 INDIA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 192
TABLE 221 INDIA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 222 INDIA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 223 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 193
TABLE 224 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 194
TABLE 225 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 194
TABLE 226 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 194
11.4.4 AUSTRALIA 194
11.4.4.1 High prevalence of cancer to drive demand for bronchoscopy 194
TABLE 227 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 195
TABLE 228 AUSTRALIA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 229 AUSTRALIA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 196
TABLE 230 AUSTRALIA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 231 AUSTRALIA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 232 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 233 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 197
TABLE 234 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 197
TABLE 235 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 197
11.4.5 REST OF ASIA PACIFIC 198
TABLE 236 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 198
TABLE 237 REST OF ASIA PACIFIC: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 238 REST OF ASIA PACIFIC: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 199
TABLE 239 REST OF ASIA PACIFIC: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 240 REST OF ASIA PACIFIC: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 241 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 200
TABLE 242 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 200
TABLE 243 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 201
TABLE 244 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 201

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/03 10:27

162.61 円

175.23 円

209.12 円

ページTOPに戻る